Pancreas 2016 Report
Pancreas 2016
The International Conference on Pancreatic Disorders and Treatment (Pancreas 2016) hosted by Conference Series LLC took place at Chicago, USA during October 17-19, 2016. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals as well as from eminent scientists, talented researchers and young student community. Researchers and students who attended from different parts of the world has made the conference one of the most successful and productive events in 2016 from Conference Series LLC. The conference was marked with the presence of renowned scientists, talented young researchers, students and business delegates driving the two days event into the path of success with thought provoking keynote and plenary presentations highlighting the theme, “Innovations in Pancreatic Research and Treatment”.
Pancreas 2016 Organizing Committee would like to thank the Moderator of the conference, Naomi Walsh, National Institute for Cellular Biotechnology, Ireland. Who contributed meticulously and exuberantly for the smooth functioning of this event.
The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following topics were highlighted as Keynote-presentations:
“Endoscopic ultrasonography(EUS) for diagnosis and treatment of pancreatic cystic lesions: Primary results of a prospective single-center study of 120 patients” by Enqiang Linghu, Chinese PLA General Hospital, China
“Development of Targeted Therapies for Pancreatic Cancer” by Pinku Mukherjee, University of North Carolina at Charlotte, USA
“Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGF-ï¢1-induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p” by Rajgopal Govindarajan, Ohio State University, USA
“Novel nutraceuticals GZ17-06.02 suppresses pancreatic cancer tumorigenesis and metastasis by inhibiting cancer stem cells” by Animesh Dhar, University of Kansas Medical Center, USA
“Conquering K-RAS-Driven Human Pancreatic Cancer by Attacking its Achilles’ Heel, SIAH Proteolysis – A Major K-RAS Vulnerability and K-RAS Downstream Signaling “Gatekeeper” by Amy H Tang, Eastern Virginia Medical School, USA
Pancreas 2016 is known for uplifting the allied areas by encouraging students and fellow researchers to present their work through poster presentations and young research forum.
Conference Series LLC has taken the privilege of felicitating Pancreas 2016 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conference Series LLC, on behalf of the conference sponsor appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavors.
The esteemed guests, Keynote speakers, well-known researchers and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Pancreas 2016 Conference. We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series LLC “Journal of Pancreatic Disorders & Therapy” as a special issue.
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Pancreas 2016. With the unique feedbacks from the conference, Conference Series LLC would like to announce the commencement of the “2nd International Conference on Pancreatic Disorders and Treatment", during Sept 14-15, 2017 Dallas, USA.
Let us meet again @ Pancreas 2017
Contact details
Kristy Jones
Program Director – Pancreas 2017
T: 650-268-9744 | M: 702-508-5200 Ext-8033
|